Characterization of pentosan polysulfate patients for development of an alert and screening system for ophthalmic monitoring

Pentosan polysulfate (PPS; ELMIRON, Janssen Pharmaceuticals, Titusville, NJ) is a U.S. Food and Drug Administration–approved oral medication for interstitial cystitis. Numerous reports have been published detailing retinal toxicity with the use of PPS. Studies characterizing this condition are prima...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Canadian journal of ophthalmology 2024-04, Vol.59 (2), p.128-136
Hauptverfasser:	Hom, Grant L., Kuo, Blanche L., Ross, James H., Chapman, Graham C., Sharma, Neha, Sastry, Resya, Muste, Justin C., Greenlee, Tyler E., Conti, Thais F., Singh, Rishi P., Sharma, Sumit
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!